|
 Dr. Wulf H. Utian, consultant in women’s health and reproductive endocrinology, has served as Editor-in-Chief of Menopause Management since its inception in 1988. The Arthur H. Bill Professor Emeritus of Reproductive Biology and Obstetrics and Gynecology, Case Western Reserve University School of Medicine, he is also Consultant, Obstetrics, Gynecology and Women's Health Institute, Cleveland Clinic, and Executive Director of The North American Menopause Society (NAMS). He is Chairman of the Advisory Board of Rapid Medical Research, Cleveland. He received his medical degree from the University of Witwatersrand, Johannesburg, South Africa, and his PhD from the University of Cape Town, South Africa, and is a Fellow of the Royal and American Colleges of Obstetricians and Gynecologists, as well as the International College of Surgeons. In 2007, he earned the DSc(Med) degree at the University of Cape Town, its highest degree, awarded only 11 times in over 100 years.
A pioneer in women’s health issues and menopause research, in 1967 he established the Groote Schuur Menopause Research Clinic in Cape Town, the world’s first such clinic. He was one of the three original founders of the International Menopause Society in 1976, of which he is Honorary Past President, and founded The North American Menopause Society in 1989.
He is the recipient of numerous national and international awards and research grants, and is still an active investigator with multiple grants. Dr. Utian has written over 200 papers related to the reproductive system in women and has authored five books on menopause and its effects on women. He is editor of Menopause: The Journal of The North American Menopause Society.
An independent consultant in women’s health, Dr. Utian has provided consultant/advisory services within the past 12 months on multiple drugs and drug families to Roche/GlaxoSmithKline, Boniva OB/GYN Advisory Board, Pfizer, Berlex, Organon, Barr/Duramed, Merck Gynecology Advisory Board, GSK SERM Global Advisory Board, Eli Lilly Breast Cancer Risk Reduction Advocacy Advisory Board, Novo Nordisk, Depomed, Gerson Lehrman, McKinsey, Goldman Sachs, and Bradley.
You need Acrobat Reader software to view and print the editorials.
Find help downloading Acrobat Reader.
Copyright by HealthCom Media. All rights reserved.
For further information or permissions, please contact the Publisher.
November/December 2009
Life is a Book, and it is Time for my Next Chapter
September/October 2009
Do You Deserve your Patients' Trust?
July/August 2009
Lesbian Women Traversing Menopause
May/June 2009
Skin: Impact of Menopause, Aging and Hormones
March/April 2009
McCarthyism is Alive and Well—This Time the Target is the Medical Profession
January/February 2009
Bisphosphonates and Unusual Fractures: Red Herring or Tip of the Iceberg?
November/December 2008
NAMS at 20: From Grass Roots Inception to International Preeminence
September/October 2008
Memory,Menopause and Hormones—Conclusions from the NAMS 2008 HT Position Statement
July/August 2008
HSDD and the Testosterone Dilemma
May/June 2008
Working with What You Have, Not What You Wish For
March/April 2008
Be a Menopause Practitioner and Escape the Trend of Medical Fragmentation
January/February 2008
A Menopause Quiz: You Complete My Editorial
November/December 2007
Time for Another Letter to Congress
September/October 2007
If Only WHI had Kept to its Premise—But Now it’s Time for their Mea Culpa
July/August 2007
Random Menopause—Related Thoughts: A Look Back Over 20 Years
May/June 2007
Menopause, Estrogen and Hearing
March/April 2007
The North American Menopause Society’s March 2007 Hormone Therapy Position Statement: Background,
Process and Clinical Implementation
January/February 2007
Feminine Forever, Round 2: The Bioidentical Cult
November/December 2006
The Dramatic Growth of NAMS— and Now the NAMS Foundation!
September/October 2006
Is Evidence-Based Medicine a Pipe Dream?
July/August 2006
Reconsidering Postmenopausal Estrogen Therapy and Breast Cancer
May/June 2006
Low Back Pain: Management Dilemmas
March/April 2006
The Psychosocial and Socioeconomic Burden of Menopausal Vasomotor Symptoms
January/February 2006
Women’s Voices For Change—A New Voice for Women and a New Partner for NAMS
November/December 2005
Domestic Violence and Menopause
September/October 2005
Selling Menopause
July/August 2005
The True Symptoms Associated with Menopause Confirmed after 33 Years: Better Late than Never,
But Let’s Move on Now!
May/June 2005
The What and the Who of Contemporary Menopause Management
March/April 2005
Pregnancy After Menopause and The North American Menopause Society (NAMS)
January/February 2005
Osteoporosis-Related Events Negatively Impact Quality of Life, But Does Quality of Life Impact the
Outcome of Osteoporosis?
November/December 2004
Development and Clinical Application of Guidelines, Consensus Opinions, and Position Statements—
The Need for Clinical Judgment Beyond the Evidence
September/October 2004
If Drugs Can Prevent Disease, Why is Continuance so Poor?
July/August 2004
Women’s Health Initiative, Round 2—Is This the Opportunity to Clear the Air on Postmenopausal Hormone Use?
May/June 2004
Menopause and Systemic Hormones in the HIV-Infected Woman
March/April 2004
Integrity of Scientific Clinical Publications and Media Reporting—Credible Information or Imaginative Marketing?
January/February 2004
Apples are not Oranges—Prevention and Treatment are Different!
November/December 2003
Does “Statistically Significant” Always Equate to “Clinically Relevant?” |